Short Interest in Orion Oyj (OTCMKTS:ORINF) Grows By 26.2%

Orion Oyj (OTCMKTS:ORINF) saw a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 377,800 shares, a growth of 26.2% from the April 30th total of 299,300 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.

Orion Oyj Stock Performance

Shares of Orion Oyj stock opened at $48.65 on Thursday. Orion Oyj has a fifty-two week low of $48.65 and a fifty-two week high of $48.65. The stock has a 50 day moving average of $48.62 and a 200 day moving average of $48.56.

About Orion Oyj

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.